financial condition, stockholders equity or results of operations of the Issuer (a Material Adverse Effect) or materially affect the validity of the Acquired Shares or
the legal authority of the Issuer to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of the Issuer; or (iii) any statute or any judgment, order, rule or regulation of any
court or governmental agency or body, domestic or foreign, having jurisdiction over the Issuer or any of its properties that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or materially affect the
validity of the Acquired Shares or the legal authority of the Issuer to comply in all material respects with this Subscription Agreement.
e. There are no securities or instruments issued by or to which the Issuer is a party containing anti-dilution or similar provisions that will
be triggered by the issuance of (i) the Acquired Shares or (ii) the Series A Shares to be issued pursuant to any Other Subscription Agreement, in each case, that have not been or will not be validly waived on or prior to the Closing Date.
f. The Issuer is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute
a default or violation) of any term, condition or provision of (i) the organizational documents of the Issuer, (ii) any loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement, permit, franchise or license to
which the Issuer is now a party or by which the Issuers properties or assets are bound or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction
over the Issuer or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that have not had and would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.
g. The Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the Issuer of this Subscription Agreement
(including, without limitation, the issuance of the Acquired Shares), other than (i) the filing with the Securities and Exchange Commission (the Commission) of the Registration Statement (as defined below), (ii) filings
required by applicable state or federal securities laws, (iii) the filings required in accordance with Section 9(n), (iv) those required by the Nasdaq Global Market (the Nasdaq), including with
respect to obtaining stockholder approval, and (v) the failure of which to obtain would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.
h. The authorized capital stock of the Issuer consists of (i) 100,000,000 shares of Series A common stock, (ii) 10,000,000 shares of Series B
common stock, and (iii) 1,000,000 shares of preferred stock, in each case, par value $0.0001 per share. As of the date of this Subscription Agreement, 8,167,390 shares of Series A common stock and 1 share of Series B common stock are issued and
outstanding, all of which are validly issued, fully paid and non-assessable.
i. The Issuer has
not received any written communication, from a governmental entity that alleges that the Issuer is not in compliance with or is in default or violation of any applicable law, except where such non-compliance,
default or violation would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.
j. The issued
and outstanding Series A Shares are registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and are listed for trading on the Nasdaq. There is no suit,
action, proceeding or investigation pending or, to the knowledge of the Issuer, threatened against the Issuer by the Nasdaq or the Commission with respect to any intention by such entity to deregister the Series A Shares or prohibit or terminate the
listing of the Series A Shares on the Nasdaq, except as disclosed in the Issuers SEC Documents (as defined below). The Issuer has taken no action that is designed to terminate the registration of the Series A Shares under the Exchange Act.
k. Assuming the accuracy of Subscribers representations and warranties set forth in Section 4, no
registration under the Securities Act is required for the offer and sale of the Acquired Shares by the Issuer to Subscriber in the manner contemplated by this Subscription Agreement.
4